Mark Rattray - whats up in Oncology?

Quote

Anonymous

Guest
Heard the head of the RMLs team (Rattray) has left. Did he resign or was he canned (by Stansbury or Hugh-Jones)?

This is a grievous loss to oncology with the launch of jevtana and the upcoming launch of iniparib.
 






Mark is a great guy. He quit since he and Charles don't have the same "vision". Too much disruption with a new launch! It will be a major loss. This is the sanofi way. If you don't drink the koolaide there must be something wrong with you.
 






Huge loss for s-a. Mark is a strong leader and will be missed. All of this disintegration of the team has occurred since Charles arrived. Hello? Maybe Mark knew too much about Charles's past unethical behavior. Bad timing given our launches.
 






I worked for him when he was in metabolism and thought he was the biggest sell-out I had ever met. I will make sure I don't see his name come up anywhere close to where I am working.
 






Anonymous said:
I worked for him when he was in metabolism and thought he was the biggest sell-out I had ever met. I will make sure I don't see his name come up anywhere close to where I am working.
Click to expand...

How true! I saw him in action a number of times. He talks a good game in front of you then does whatever he needs to do to survive.
He fits right in with the other so called leadership at SA oncology. Not sure why he would leave an environment that he was suited to!! lol
 












Top Bottom
Back
Quote